Lin J H
Arthritis Clinic and Research Center, People's Hospital, Beijing Medical University.
Zhonghua Wai Ke Za Zhi. 1993 Sep;31(9):542-4.
From June 1991 to February 1992, an autologous blood transfusion program was employed for 26 rheumatic patients in this hospital. Among them, 16 were diagnosed as rheumatoid arthritis (RA), 6 osteoarthritis (OA) and 4 ankylosing spondylitis (AS). Knee synovectomy was performed for 7 patients and total hip or knee arthroplasty for the other 19 patients. The total amount of blood autotransfused was 15,200 ml, which accounted for 89.4% of the total blood transfusion during the operation. Twenty-one patients (80.7%) received only autologous blood, while the other 5 (19.3%) required additional homologous blood. Only one adverse reaction occurred in one patient who received homologous blood. By the observation of a series of clinical and immunological indices, no aggravation was seen. Therefore we believe a program of prior deposit and storage of autologous blood for rheumatic patients, who need surgical treatment, is both cost-effective and safe.
1991年6月至1992年2月,本院对26例风湿性疾病患者采用了自体输血方案。其中,16例被诊断为类风湿关节炎(RA),6例为骨关节炎(OA),4例为强直性脊柱炎(AS)。7例患者接受了膝关节滑膜切除术,另外19例患者接受了全髋关节或膝关节置换术。自体输血总量为15200毫升,占手术期间总输血量的89.4%。21例患者(80.7%)仅接受了自体血,另外5例(19.3%)需要额外的异体血。接受异体血的1例患者仅出现1次不良反应。通过观察一系列临床和免疫学指标,未见病情加重。因此,我们认为,为需要手术治疗的风湿性疾病患者预先储存自体血的方案既具有成本效益又安全。